Alkaline phosphatase · children with X‐linked hypophosphataemia
1 finding from 1 review
Measures of renal function: change in TmP/GFR · children with X‐linked hypophosphataemia
It is very uncertain whether summary of findings ‐ recombinant growth hormone changes measures of renal function: change in TmP/GFR compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Body proportions: sitting height SDS · children with X‐linked hypophosphataemia
Summary of findings ‐ recombinant growth hormone showed no clear difference in body proportions: sitting height SDS compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
Adverse effects · children with X‐linked hypophosphataemia
1 finding from 1 review
Change in cramp frequency (cramps per night) (after 6 weeks) · older adults with lower limb muscle cramps
1 finding from 1 review
Adverse events · older adults with lower limb muscle cramps
1 finding from 1 review
Change in cramp severity (0 to 10 VAS; higher = worse pain) (after 6 weeks) · older adults with lower limb muscle cramps
1 finding from 1 review
Proportion of participants experiencing cramps · older adults with lower limb muscle cramps
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · older adults with lower limb muscle cramps
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of sleep · older adults with lower limb muscle cramps
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · older adults with lower limb muscle cramps
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in live birth rate compared with other active intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with other active intervention (moderate certainty).
1 finding from 1 review
Multiple pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in multiple pregnancy rate compared with other active intervention (low certainty).
1 finding from 1 review
Miscarriage · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in miscarriage rate compared with other active intervention (low certainty).
1 finding from 1 review
Any other adverse events · women undergoing assisted reproduction
1 finding from 1 review
Live birth rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in live birth rate compared with placebo/no intervention (low certainty).
1 finding from 1 review
Clinical pregnancy rate · women undergoing assisted reproduction
Dopamine agonist showed no clear difference in clinical pregnancy rate compared with placebo/no intervention (low certainty).
1 finding from 1 review